To achieve this it is vital that pharmaceutical companies enhance their knowledge of consumers. They should build extensive consumer databases (requiring patient consent) that feature detailed information on different consumer types. These databases should provide a clear picture of the medical conditions of listed consumers and their potential health risks, occupations, household revenues and numerous other socio-demographic factors.
Ultimately, the information collected can enable companies to segment the target population according to different preferences and emotional profiles.
